AliveCor QT Service vs iCAC Device

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AliveCor
VS
by Bunkerhill Health

AI Verdict

Tool A specializes in assessing cardiac safety by measuring QT intervals from ECGs, primarily informing medication prescribing decisions. In contrast, Tool B analyzes CT scans to detect and quantify coronary artery calcium, aiding in early cardiovascular disease risk assessment. While both are cardiology AI tools, their distinct data inputs and specific clinical applications make them complementary rather than direct competitors.

Choose AliveCor QT Service if…

Choose AliveCor QT Service if you need to rapidly and accurately assess cardiac safety, particularly concerning medication effects on QT intervals. This tool is ideal for healthcare professionals who require instant, precise QT and QTc measurements from AliveCor 6-Lead ECGs to inform critical medication prescribing decisions and monitor for potential drug-induced arrhythmias.

View AliveCor QT Service →

Choose iCAC Device if…

Choose Bunkerhill Health's iCAC Device if your goal is to opportunistically identify and quantify coronary artery calcium from routine, non-contrast chest CT scans. This AI-powered solution is best suited for radiologists and cardiologists seeking to leverage existing imaging data for early cardiovascular disease detection and risk stratification, providing valuable adjunctive information without requiring dedicated cardiac CTs.

View iCAC Device →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AliveCor QT Service iCAC Device
Pricing Varies by product and service, with subscription options available. Contact for pricing
Deployment Mobile app, cloud-based platform, EHR integration. Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

iCAC Device

Tool B integrates seamlessly into existing radiology workflows by analyzing routine CT scans and integrating with PACS or DICOM routers. While Tool A integrates with its own ecosystem and offers APIs, it requires the use of specific AliveCor 6-Lead ECG devices, which introduces a hardware dependency not present with Tool B's use of existing imaging data.

Clinical Value

Tie

Both tools offer significant and FDA-cleared clinical value in distinct areas of cardiology. Tool A enhances cardiac safety by providing instant QT interval measurements for medication management, while Tool B aids in early cardiovascular disease detection through coronary artery calcium quantification from routine CT scans. Their value propositions are different but equally impactful in their respective clinical contexts.

Pricing & Value

Tie

Neither tool provides transparent pricing information, both requiring direct contact with the vendor for details. Without access to pricing, it is impossible to conduct a meaningful comparison of their cost-effectiveness or overall value proposition.

Enterprise Readiness

AliveCor QT Service

Tool A explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in place, which are fundamental requirements for healthcare enterprise adoption. Tool B, while FDA-cleared and offering integration, requires contacting the vendor for details on HIPAA compliance and BAA, indicating less upfront transparency in these critical areas for enterprise deployment.

Innovation

iCAC Device

Both tools leverage AI/deep learning. Tool A provides instant QT measurements from mobile ECGs. However, Tool B's innovation in opportunistically detecting and quantifying coronary artery calcium from *routine, non-contrast, non-gated chest CT scans* that were performed for other reasons is particularly impactful, as it extracts new, vital cardiovascular risk information from existing data without requiring additional procedures or radiation exposure.

Support & Docs

AliveCor QT Service

AliveCor (Tool A) is a more established company with a broader product ecosystem (Kardia devices, KardiaPro) and a more mature professional support infrastructure, including readily available resources and documentation for its various offerings. Bunkerhill Health (Tool B), while innovative, has less readily available specific support and documentation information for its iCAC Device in public search results, suggesting a potentially less developed support framework.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AliveCor QT Service iCAC Device
Name AliveCor QT Service iCAC Device
Company AliveCor Bunkerhill Health
Description A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. Bunkerhill Health's iCAC Device is an FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection.
Key Functionality Measures QT and QTc intervals from AliveCor 6-Lead ECGs for cardiac safety assessment. Detects and quantifies coronary artery calcium from routine chest CT scans.
Input Data Type AliveCor 6-Lead ambulatory ECGs Routine, non-contrast, non-gated chest CT scans
Target User Qualified healthcare professionals (Prescription (Rx) use only) Radiologists (provides adjunctive information)
Integration KardiaStation app, KardiaPro portal, API for EHR, SDK, CRM, EDC, PSP platforms EHRs via the Carebricks platform, PACS or DICOM router

Videos

Demos, reviews, and walkthroughs featuring AliveCor QT Service and iCAC Device.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The AliveCor QT Service is a cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, primarily to assess cardiac safety and inform medication prescribing decisions. In contrast, the iCAC Device is an FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection.
The AliveCor QT Service analyzes electrocardiograms (ECGs) obtained from AliveCor 6-Lead ambulatory ECG devices. The iCAC Device analyzes routine, non-contrast, non-gated chest CT scans.
The AliveCor QT Service provides instant QT and QTc interval measurements, utilizing Bazett's and Fridericia's formulas. The iCAC Device outputs a visual representation of estimated coronary artery calcium segmentation and delivers exact and four-category quantitative estimates of CAC burden in Agatston units.
The AliveCor QT Service is intended for use by qualified healthcare professionals in specialties such as Cardiology, Emergency Medicine, and Internal Medicine. The iCAC Device is primarily designed to provide adjunctive information to radiologists and is relevant for Cardiology and Radiology specialties.
The AliveCor QT Service integrates with the KardiaStation app and KardiaPro portal, and offers an API for integration with EHR, SDK, CRM, EDC, and PSP platforms. The iCAC Device integrates with PACS or DICOM routers and can integrate with EHRs via its cloud-based Carebricks platform.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.